EverSource Wealth Advisors »

Celldex Therapeutics shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.8k 262 25.83
2025-06-30 $3.5k 171 20.33
2025-03-31 $26k 1.4k 18.15
2024-12-31 $33k 1.3k 25.26
2024-09-30 $14k 407 34.00
2024-06-30 $16k 407 38.11
2024-03-31 $16k 418 37.41
2023-12-31 $1.5k 39 39.69

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
iShares Gold Trust ETF Etf (IAU)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Microsoft Corp Stock (MSFT)
Tesla Stock (TSLA)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Total Stock Market Etf Etf (VTI)
Broadcom Stock (AVGO)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for EverSource Wealth Advisors

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics